The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Nuvation Bio (NUVB) announced it has initiated an Expanded Access Program or EAP for taletrectinib in the U.S. for the treatment of patients ...

A Maricopa County judge found Ashley Reynolds "unilaterally and impermissibly" used Relentless Media funds to pay herself ...

New York, New York-- (Newsfile Corp. - February 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company, has announced a 1-for-100 reverse stock split of its common stock, set to take effect as trading opens ...

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for ...

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

NEW YORK - Nuvation Bio Inc. (NYSE:NUVB), a biopharmaceutical company focused on oncology with a market capitalization of $777 million, has launched an Expanded Access Program (EAP) in the United ...

On January 24, 2025, the Fifth Circuit Court of Appeals struck down an FTC rule aimed at curbing deceptive advertising and sales practices in the ...

On January 30, 2025, the CFPB issued an order against a remittance company for misleading consumers about fees and failing to provide ...

PM Modi reaffirmed his commitment to women's empowerment, announcing loans up to Rs 2 crore and business training for women entrepreneurs. He also highlighted BJP's success in financial aid, bank ...

Data from the phase 3 ENVISION trial demonstrate the potential of UGN-102 as an effective and durable nonsurgical treatment for patients with low-grade, intermediate-risk non–muscle-invasive bladder ...